Neurology News

Treatment for relapsing-remitting MS improved in a “clinically meaningful” way between 2010 and 2018, in part due to the availability of new, primarily oral disease-modifying therapies, according to findings published in BMJ Open Access.

Moderna has announced that its COVID-19 vaccine was 93% effective, with “durable” efficacy lasting at least 6 months after administration of the second dose.

Surgery for mesial temporal lobe epilepsy correlated with a reduction in imaging-defined brain age, indicating that morphological brain changes related to accelerated aging may be reversible, according to a study published in Neurology.

In a recent letter to Congress, 430 organizations urged policymakers to preserve access to telehealth services for Medicare beneficiaries and advance permanent telehealth reform.

Among patients with stroke who presented early after symptom onset, those treated by a mobile stroke unit were more functionally independent at 90 days compared with those treated with the “drip and ship” method, researchers reported.

Midodrine, when administered in tandem with guidance on lifestyle risk reduction, lowered the recurrence of vasovagal syncope among patients who experienced fainting spells, data show.

Direct transfer to an angiography suite within 6 hours of stroke onset increased rates of endovascular therapy, reduced hospital workflow time and enhanced clinical outcomes, according to findings published in JAMA Neurology.

The AMA has announced the CPT codes for a third dose of the Pfizer-BioNTech COVID-19 vaccine if one is authorized or approved by the FDA.

Among patients with ischemic stroke and mismatch imaging profiles, the performance of endovascular thrombectomy correlated with improvements in clinical outcomes, according to a study published in JAMA Neurology.

More physical activity and less time spent sedentary were associated with a lower incidence of obstructive sleep apnea, according to new results published in the European Respiratory Journal.